Healthcare Sector Review: Winning and Losing Stocks on Nov 17th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • ZOLL Medical Corporation (NASDAQ:ZOLL): The shares closed at $43.84, up $8.18, or 22.94%, on the day. Its market capitalization is $970.61 million. About the company: Zoll Medical Corporation designs, manufactures, and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. The Company’s products are used by health care professionals to provide pacing and defibrillation. Zoll also designs and markets software that automates collection and management of data for emergency medical service providers. Get the most recent company news and stock data here >>
  • Dendreon Corporation (NASDAQ:DNDN): The shares closed at $8.11, up $0.6, or 7.99%, on the day. Its market capitalization is $1.21 billion. About the company: Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body’s key defense against cancer. Get the most recent company news and stock data here >>
  • Synta Pharmaceuticals (NASDAQ:SNTA): The shares closed at $3.44, up $0.22, or 6.83%, on the day. Its market capitalization is $170.27 million. About the company: Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies. Get the most recent company news and stock data here >>
  • Salix Pharmaceuticals (NASDAQ:SLXP): The shares closed at $35.97, up $2.07, or 6.11%, on the day. Its market capitalization is $2.13 billion. About the company: Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force. Get the most recent company news and stock data here >>
  • Cadence Pharmaceuticals (NASDAQ:CADX): The shares closed at $3.98, up $0.19, or 5.01%, on the day. Its market capitalization is $253.19 million. About the company: Cadence Pharmaceuticals Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections. Get the most recent company news and stock data here >>

Losers (% price change)

  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $8.68, down $0.69, or 7.36%, on the day. Its market capitalization is $679.59 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. Get the most recent company news and stock data here >>
  • BioCryst Pharmaceuticals (NASDAQ:BCRX): The shares closed at $2.71, down $0.2, or 6.87%, on the day. Its market capitalization is $122.53 million. About the company: BioCryst Pharmaceuticals, Inc., a biopharmaceutical company, discovers and designs novel small-molecule pharmaceuticals using structure-based drug design. The Company’s products are used for the treatment of immunological, viral, and cardiovascular diseases and disorders. BioCryst’s lead immunological drug program targets T-cell proliferative disorders. Get the most recent company news and stock data here >>
  • Human Genome Sciences (NASDAQ:HGSI): The shares closed at $8.16, down $0.58, or 6.64%, on the day. Its market capitalization is $1.62 billion. About the company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes. Get the most recent company news and stock data here >>
  • Tenet Healthcare Corp. (NYSE:THC): The shares closed at $4.55, down $0.28, or 5.8%, on the day. Its market capitalization is $1.98 billion. About the company: Tenet Healthcare Corporation, through its subsidiaries, owns or operates general hospitals and related health care facilities serving communities in the United States. The Company operates rehabilitation hospitals, specialty hospitals, long-term care facilities, psychiatric facilities, and medical office buildings near its general hospitals, as well as ancillary health care businesses. Get the most recent company news and stock data here >>
  • EXACT Sciences Corp. (NASDAQ:EXAS): The shares closed at $7.82, down $0.47, or 5.67%, on the day. Its market capitalization is $413.91 million. About the company: Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company’s test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>